US BANCORP \DE\ - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 205 filers reported holding CARDLYTICS INC in Q4 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.9%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$1,452
-51.6%
88
-72.8%
0.00%
Q3 2022$3,000
-66.7%
323
-19.0%
0.00%
Q2 2022$9,000
+350.0%
399
+1008.3%
0.00%
Q1 2022$2,000
-50.0%
36
-42.9%
0.00%
Q4 2021$4,000
-82.6%
63
-77.0%
0.00%
Q3 2021$23,000
-25.8%
274
+13.2%
0.00%
Q2 2021$31,000
+287.5%
242
+245.7%
0.00%
Q1 2021$8,000
-38.5%
70
-21.3%
0.00%
Q4 2020$13,000
+116.7%
89
+6.0%
0.00%
Q3 2020$6,000
+500.0%
84
+460.0%
0.00%
Q2 2020$1,000150.00%
Other shareholders
CARDLYTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 5,416,116$89,365,91411.46%
KPS Global Asset Management UK Ltd 1,218,830$20,110,69510.97%
WORLDLY PARTNERS MANAGEMENT, LLC 996,881$16,448,53710.50%
General Equity Holdings LP 476,215$7,857,5489.59%
BERYLSON CAPITAL PARTNERS, LLC 195,000$3,217,5008.24%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 454,769$7,503,6895.27%
PB INVESTMENT PARTNERS, L.P. 343,061$5,660,5064.83%
VISA INC. 134,914$2,226,0812.50%
683 Capital Management, LLC 1,760,070$29,041,1562.26%
Antipodean Advisors LLC 20,000$330,0001.69%
View complete list of CARDLYTICS INC shareholders